Cencora Continues Its Investment in Third-Party Logistics
Cencora, which is often termed as being one of the Big Three wholesalers, is continuing to go ahead and invest in its third-party logistics...
Lilly, IU Deepen Work on Clinical Trial Innovation Ecosystem
Eli Lilly and Company has entered a five-year collaboration with Indiana University that will provide up to $40 million to expand clinical trial access...
PLI Incentives Aim to Accelerate API Manufacturing in India
India's Department of Pharmaceuticals has launched a fresh application round under the Production Linked Incentive (PLI) Scheme targeting two high-priority active pharmaceutical ingredients, Meropenem,...
Advanced Clinical Trial Support Hub Launched in South Korea
Leading healthcare solutions company in Asia, Zuellig Pharma, on November 30, 2025, confirmed through an announcement the grand opening of its new state-of-the-art Clinical...
A Possible New US Manufacturing Hub from Novartis
In a latest move, a pharma major has announced its plans to build a new US manufacturing hub based out of North Carolina. The...
Merck Announces Acquisition of Cidara Therapeutics at $9.2 B
Merck announced that it will acquire Cidara Therapeutics, Inc., after both companies confirmed they have signed a definitive agreement. The deal, executed through a...
Novartis Opens Radioligand Therapy Manufacturing Plant in US
Novartis, a leader in innovative medicines, has launched a 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California. The site marks an important step...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...